[go: up one dir, main page]

CY1120945T1 - Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων - Google Patents

Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων

Info

Publication number
CY1120945T1
CY1120945T1 CY181101057T CY181101057T CY1120945T1 CY 1120945 T1 CY1120945 T1 CY 1120945T1 CY 181101057 T CY181101057 T CY 181101057T CY 181101057 T CY181101057 T CY 181101057T CY 1120945 T1 CY1120945 T1 CY 1120945T1
Authority
CY
Cyprus
Prior art keywords
genetically
genetically modified
receptor mice
modeled cell
creation
Prior art date
Application number
CY181101057T
Other languages
English (en)
Inventor
Lynn Macdonald
Andrew J Murphy
John Mcwhirter
Naxin Tu
Vera Voronina
Cagan Gurer
Karolina Meagher
Sean Stevens
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of CY1120945T1 publication Critical patent/CY1120945T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0387—Animal model for diseases of the immune system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Η εφεύρεση παρέχει ένα γενετικώς τροποποιημένο τρωκτικό το οποίο περιλαμβάνει στο γονιδίωμα του μη αναδιατεταγμένους μεταβλητούς γονιδιακούς τόπους υποδοχέα Τ κυττάρων, καθώς επίσης μη-ανθρώπινα έμβρυα, κύτταρα και ιστούς που τους περιλαμβάνουν. Παρέχονται επίσης κατασκευάσματα για δημιουργία του εν λόγω γενετικώς τροποποιημένου μη-ανθρώπινου ζώου και μέθοδοι δημιουργίας τους. Διάφορες μέθοδοι χρήσης του γενετικώς τροποποιημένου μη-ανθρώπινου ζώου επίσης παρέχονται.
CY181101057T 2011-10-28 2018-10-16 Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων CY1120945T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161552582P 2011-10-28 2011-10-28
US201261621198P 2012-04-06 2012-04-06
US201261700908P 2012-09-14 2012-09-14
PCT/US2012/062065 WO2013063361A1 (en) 2011-10-28 2012-10-26 Genetically modified t cell receptor mice

Publications (1)

Publication Number Publication Date
CY1120945T1 true CY1120945T1 (el) 2019-12-11

Family

ID=47178340

Family Applications (2)

Application Number Title Priority Date Filing Date
CY181101057T CY1120945T1 (el) 2011-10-28 2018-10-16 Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων
CY20211100142T CY1123831T1 (el) 2011-10-28 2021-02-19 Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20211100142T CY1123831T1 (el) 2011-10-28 2021-02-19 Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων

Country Status (25)

Country Link
US (4) US9113616B2 (el)
EP (3) EP3795587A1 (el)
JP (7) JP6254528B2 (el)
KR (5) KR102542272B1 (el)
CN (5) CN114891797A (el)
AU (5) AU2012327204B2 (el)
BR (1) BR112014009203B1 (el)
CA (1) CA2853707A1 (el)
CY (2) CY1120945T1 (el)
DK (2) DK2771357T3 (el)
ES (2) ES2858978T3 (el)
HR (2) HRP20181626T1 (el)
HU (1) HUE053444T2 (el)
IL (4) IL315445A (el)
IN (1) IN2014CN03890A (el)
LT (2) LT3424947T (el)
MX (2) MX353134B (el)
PL (2) PL3424947T3 (el)
PT (2) PT2771357T (el)
RS (2) RS61455B1 (el)
RU (1) RU2661106C2 (el)
SG (2) SG11201401030WA (el)
SI (2) SI2771357T1 (el)
SM (2) SMT201800553T1 (el)
WO (1) WO2013063361A1 (el)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX353134B (es) * 2011-10-28 2017-12-20 Regeneron Pharma Ratones con receptor de linfocitos t modificados geneticamente.
US20150073043A1 (en) * 2012-01-19 2015-03-12 Institut Pasteur Of Shanghai, Chinese Academy Of Sciences Use of phosphorylation pathway-related factor in regulating function of regulatory t cell
PT2847335T (pt) 2012-04-25 2018-09-28 Regeneron Pharma Alvejamento mediado por nuclease com vetores de alvejamento grandes
GB2508414A (en) * 2012-11-30 2014-06-04 Max Delbrueck Centrum Tumour specific T cell receptors (TCRs)
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
PL3456831T3 (pl) 2013-04-16 2021-12-06 Regeneron Pharmaceuticals, Inc. Ukierunkowana modyfikacja genomu szczura
AU2014360811B2 (en) 2013-12-11 2017-05-18 Regeneron Pharmaceuticals, Inc. Methods and compositions for the targeted modification of a genome
TWI681969B (zh) * 2014-01-23 2020-01-11 美商再生元醫藥公司 針對ｐｄ-１的人類抗體
WO2015188109A1 (en) * 2014-06-06 2015-12-10 Regeneron Pharmaceuticals, Inc. Methods and compositions for modifying a targeted locus
SG10201811116UA (en) * 2014-06-19 2019-01-30 Regeneron Pharma Non-human animals having a humanized programmed cell death 1 gene
RU2711740C2 (ru) 2014-06-26 2020-01-21 Регенерон Фармасьютикалз, Инк. Способы и композиции для нацеленных генетических модификаций и способы их применения
SG11201701040XA (en) * 2014-09-19 2017-03-30 Regeneron Pharma Chimeric antigen receptors
CA3176380A1 (en) 2014-11-21 2016-05-26 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modification using paired guide rnas
ES2923775T3 (es) * 2014-11-24 2022-09-30 Regeneron Pharma Animales no humanos que expresan el complejo CD3 humanizado
CA2971213C (en) 2014-12-19 2023-09-26 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modification through single-step multiple targeting
SI3280257T1 (sl) * 2015-04-06 2023-10-30 Regeneron Pharmaceuticals, Inc., S humaniziranimi t-celicami posredovani imunski odzivi pri nehumanih živalih
EP4545082A3 (en) 2015-05-06 2025-07-02 SNIPR Technologies Limited Altering microbial populations & modifying microbiota
HUE054612T2 (hu) 2015-11-20 2021-09-28 Regeneron Pharma Humanizált limfocitaaktiváló gén 3-t tartalmazó nem-humán állatok
JP2019510503A (ja) * 2016-04-07 2019-04-18 ブルーバード バイオ， インコーポレイテッド キメラ抗原受容体ｔ細胞組成物
MD3440105T2 (ro) 2016-04-08 2022-09-30 Immunocore Ltd Receptori de celulă T
EP4567104A3 (en) * 2016-06-03 2025-09-24 Regeneron Pharmaceuticals, Inc. Rodents expressing exogenous terminal deoxynucleotidyltransferase
GB201609811D0 (en) 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
MX2019015183A (es) * 2017-06-16 2020-02-20 Mayo Found Medical Education & Res Materiales y metodos para incrementar respuestas inmunitarias.
MA50613A (fr) 2017-10-03 2020-08-12 Editas Medicine Inc Molécules de liaison spécifique à l'hpv
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
US20210017249A1 (en) * 2018-04-05 2021-01-21 Juno Therapeutics, Inc. Methods of producing cells expressing a recombinant receptor and related compositions
AU2019312008A1 (en) * 2018-07-26 2021-03-18 Kyoto University Method for generating cells into which an exogenous antigen receptor is introduced
US11851663B2 (en) 2018-10-14 2023-12-26 Snipr Biome Aps Single-vector type I vectors
AU2020344628A1 (en) * 2019-09-12 2022-04-07 TCR2 Therapeutics Inc. Compositions and methods for TCR reprogramming using fusion proteins
US20220409732A1 (en) 2019-12-02 2022-12-29 Regeneron Pharmaceuticals, Inc. Peptide-mhc ii protein constructs and uses thereof
IL296827A (en) * 2020-03-27 2022-11-01 2Seventy Bio Inc t cell receptors
CN113684258B (zh) * 2020-05-18 2024-08-20 上海赛比曼生物科技有限公司 用于检测鼠源tcr转基因拷贝数的试剂盒及方法
BR112023018874A2 (pt) 2021-03-31 2023-10-03 Regeneron Pharma Camundongos geneticamente modificados compreendendo componentes do sistema imunológico celular humanizado com diversidade melhorada do repertório de tcrb
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections
US20240114883A1 (en) * 2022-08-12 2024-04-11 Ingenious Targeting Laboratories Genetically modified non-human having humanized gamma and delta TCR variable genes
US20240092859A1 (en) 2022-08-18 2024-03-21 Immunocore Ltd T cell receptors and fusion proteins thereof
AU2023347224A1 (en) * 2022-09-22 2025-03-20 Regeneron Pharmaceuticals, Inc. Genetically modified mice expressing components of human cellular immune system
TW202520975A (zh) 2023-08-09 2025-06-01 英商劍橋企業有限公司 基因改造之囓齒動物及囓齒動物細胞以及其等用途

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1994006908A1 (en) 1992-09-11 1994-03-31 The Regents Of The University Of California Transgenic non-human animals having targeted lymphocyte transduction genes
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
US20010007152A1 (en) 1996-03-05 2001-07-05 Linda A. Sherman Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
US6320306B1 (en) * 1996-08-05 2001-11-20 Samsung Display Devices Co., Ltd. Shadow mask with porous insulating layer and heavy metal layer
PT942968E (pt) 1996-12-03 2008-03-27 Amgen Fremont Inc Anticorpos totalmente humanos que se ligam ao egfr
WO2001027291A1 (en) 1999-10-12 2001-04-19 Institut Pasteur Design of a polyepitopic construct for the induction of hla-a2.1 restricted hiv 1 specific ctl responses using hhd mice
US7462486B2 (en) 2000-05-12 2008-12-09 Oregon Health & Science University Methods of selecting T cell receptor V peptides for therapeutic use
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
AU2002222610A1 (en) 2000-12-13 2002-06-24 Sumitomo Pharmaceuticals Company, Limited Transgenic animal expressing hla-a24 and utilization thereof
US20030093818A1 (en) 2000-12-19 2003-05-15 Belmont Heather J. Transgenic animals comprising a humanized immune system
FR2827302B1 (fr) 2001-07-13 2003-10-10 Genoway Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations
ATE290020T1 (de) 2001-08-31 2005-03-15 Avidex Ltd Löslicher t zell rezeptor
JP4087338B2 (ja) 2001-11-15 2008-05-21 キリンファーマ株式会社 キメラ非ヒト動物
DK1321477T3 (da) 2001-12-22 2005-02-14 4Antibody Ag Fremgangsmåde til frembringelsen af genetisk modificerede vertebrate precursor-lymfocytter og anvendelse deraf til fremstillingen af heterologe bindende proteiner
CN100360565C (zh) 2001-12-22 2008-01-09 4-抗体股份公司 制备脊椎动物淋巴细胞和生产结合蛋白的方法
DE10244457A1 (de) 2002-09-24 2004-04-01 Johannes-Gutenberg-Universität Mainz Verfahren zur rationalen Mutagenese von alpha/beta T-Zell Rezeptoren und entsprechend mutierte MDM2-Protein spezifische alpha/beta T-Zell Rezeptoren
JP4436319B2 (ja) 2002-10-09 2010-03-24 メディジーン リミテッド 単鎖組換えｔ細胞レセプター
AU2003279820A1 (en) * 2002-10-30 2004-06-07 The Wistar Institute Of Anatomy And Biology Mouse model for autoimmune disorders
US7663017B2 (en) 2003-07-30 2010-02-16 Institut Pasteur Transgenic mice having a human major histocompatability complex (MHC) phenotype, experimental uses and applications
EP1802193B1 (en) 2004-10-19 2014-04-30 Regeneron Pharmaceuticals, Inc. Method for generating a mouse homozygous for a genetic modification
ES2382777T3 (es) * 2006-05-03 2012-06-13 Government Of The United States Of America,As Represented By The Secretary, Department Of Health And Human Services Receptor de células T quimérico y materiales relacionados y métodos de uso
EP1878342A1 (en) * 2006-07-13 2008-01-16 Institut Pasteur Immunodeficient mice transgenic for HLA class I and HLA class II molecules and their uses
US9388425B2 (en) 2006-10-20 2016-07-12 Trustees Of Boston University Tunable genetic switch for regulating gene expression
JP2008159109A (ja) 2006-12-21 2008-07-10 Matsushita Electric Ind Co Ltd データ転送装置
US20090271884A1 (en) 2008-03-07 2009-10-29 Regeneron Pharmaceuticals, Inc. ES Cell-Derived Mice From Diploid Host Embryo Injection
US20090328240A1 (en) 2008-06-24 2009-12-31 Sing George L Genetically modified mice as predictors of immune response
WO2010107400A1 (en) 2009-03-20 2010-09-23 Agency For Science, Technology And Research Genetically modified animal and method of obtaining the same
SG2014010995A (en) 2009-07-08 2014-05-29 Kymab Ltd Animal models and therapeutic molecules
GB0917090D0 (en) 2009-09-29 2009-11-11 Ucl Biomedica Plc T-cell receptor
EP2486049A1 (en) 2009-10-06 2012-08-15 The Board Of Trustees Of The UniversityOf Illinois Human single-chain t cell receptors
US8956828B2 (en) 2009-11-10 2015-02-17 Sangamo Biosciences, Inc. Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
US9557323B2 (en) 2010-09-24 2017-01-31 The United States Of America As Represented By The Secretary Of The Navy Humanized transgenic mouse model
CN103348012B (zh) 2010-11-27 2016-06-08 朱坚 一种人源化的转基因动物
MX353134B (es) * 2011-10-28 2017-12-20 Regeneron Pharma Ratones con receptor de linfocitos t modificados geneticamente.
SI3280257T1 (sl) 2015-04-06 2023-10-30 Regeneron Pharmaceuticals, Inc., S humaniziranimi t-celicami posredovani imunski odzivi pri nehumanih živalih

Also Published As

Publication number Publication date
IL305550A (en) 2023-10-01
JP2022093637A (ja) 2022-06-23
BR112014009203B1 (pt) 2023-02-28
AU2018204700B2 (en) 2021-04-01
IL274914B1 (en) 2023-10-01
DK2771357T3 (en) 2018-10-29
IL274914A (en) 2020-07-30
MX353134B (es) 2017-12-20
KR102542272B1 (ko) 2023-06-13
CN107858333B (zh) 2022-05-27
CA2853707A1 (en) 2013-05-02
CN114891798A (zh) 2022-08-12
SMT202100243T1 (it) 2021-05-07
KR20140077219A (ko) 2014-06-23
WO2013063361A1 (en) 2013-05-02
AU2018204700A1 (en) 2018-07-19
AU2018204700C1 (en) 2021-10-14
JP2018007696A (ja) 2018-01-18
EP3424947B1 (en) 2020-11-25
KR20200102001A (ko) 2020-08-28
EP2771357A1 (en) 2014-09-03
RU2661106C2 (ru) 2018-07-11
KR20220066197A (ko) 2022-05-23
JP6532924B2 (ja) 2019-06-19
EP3795587A1 (en) 2021-03-24
SMT201800553T1 (it) 2018-11-09
US20220386575A1 (en) 2022-12-08
CY1123831T1 (el) 2022-05-27
SG10201914043XA (en) 2020-03-30
IN2014CN03890A (el) 2015-10-16
PL3424947T3 (pl) 2021-06-14
ES2858978T3 (es) 2021-09-30
JP2024019646A (ja) 2024-02-09
AU2021203192B2 (en) 2024-04-11
PT3424947T (pt) 2021-03-01
RS61455B1 (sr) 2021-03-31
SG11201401030WA (en) 2014-04-28
PL2771357T3 (pl) 2018-12-31
JP2019033770A (ja) 2019-03-07
US11528895B2 (en) 2022-12-20
LT2771357T (lt) 2018-10-25
KR102148387B1 (ko) 2020-08-26
PT2771357T (pt) 2018-11-09
HUE053444T2 (hu) 2021-06-28
CN107858332A (zh) 2018-03-30
US20130109053A1 (en) 2013-05-02
HRP20210256T1 (hr) 2021-04-02
JP6706311B2 (ja) 2020-06-03
SI3424947T1 (sl) 2021-04-30
IL305550B1 (en) 2024-10-01
AU2012327204A1 (en) 2013-05-23
CN104011071A (zh) 2014-08-27
RS57893B1 (sr) 2019-01-31
JP6254528B2 (ja) 2017-12-27
JP2023024744A (ja) 2023-02-16
AU2012327204B2 (en) 2016-01-21
JP2014532413A (ja) 2014-12-08
CN104011071B (zh) 2017-11-07
IL274914B2 (en) 2024-02-01
AU2016202512C1 (en) 2018-10-11
LT3424947T (lt) 2021-03-10
HRP20181626T1 (hr) 2018-12-14
BR112014009203A2 (pt) 2020-10-27
SI2771357T1 (sl) 2018-11-30
JP7656580B2 (ja) 2025-04-03
MX2014004894A (es) 2014-09-12
AU2024204645A1 (en) 2024-08-01
ES2691475T3 (es) 2018-11-27
DK3424947T3 (da) 2021-02-22
US20160021856A1 (en) 2016-01-28
AU2021203192A1 (en) 2021-06-10
MX379517B (es) 2025-03-10
KR102397961B1 (ko) 2022-05-13
NZ623147A (en) 2016-03-31
US9113616B2 (en) 2015-08-25
KR20210133325A (ko) 2021-11-05
CN114891797A (zh) 2022-08-12
JP7305840B2 (ja) 2023-07-10
KR101964776B1 (ko) 2019-04-04
JP2020146045A (ja) 2020-09-17
RU2014121160A (ru) 2015-12-10
HK1198171A1 (en) 2015-03-13
EP2771357B1 (en) 2018-07-18
AU2016202512A1 (en) 2016-05-12
CN107858333A (zh) 2018-03-30
IL232098B (en) 2020-06-30
IL305550B2 (en) 2025-02-01
EP3424947A1 (en) 2019-01-09
US20210051930A1 (en) 2021-02-25
AU2016202512B2 (en) 2018-03-29
KR20190037354A (ko) 2019-04-05
KR102321909B1 (ko) 2021-11-05
IL232098A0 (en) 2014-05-28
IL315445A (en) 2024-11-01

Similar Documents

Publication Publication Date Title
CY1120945T1 (el) Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων
CY1121869T1 (el) Ποντικοι με γενετικα τροποποιημενο μειζον συμπλεγμα ιστοσυμβατοτητας
CY1122700T1 (el) Γενετικα τροποποιημενοι ποντικοι εκφραζοντες χιμαιρικα μορια μειζονος συμπλεγματος ιστοσυμβατοτητας (μηc) ii
CY1122036T1 (el) Μη ανθρωπινα ζωα που εκφραζουν αντισωματα τα οποια εχουν μια κοινη ελαφρια αλυσιδα
CY1124627T1 (el) Στοχευμενη τροποποιηση γονιδιωματος αρουραιου
CY1120808T1 (el) Μεθοδοι και συνθεσεις για στοχευμενες γενετικες τροποποιησεις και μεθοδοι χρησης
CY1122940T1 (el) Μη ανθρωπινα ζωα που εχουν ενα εξανθρωπισμενο γονιδιο προγραμματισμενου κυτταρικου θανατου 1
CY1121738T1 (el) Μεθοδοι και συνθεσεις για στοχευμενη γενετικη τροποποιηση χρησιμοποιωντας συζευγμενα rna-οδηγους
CY1121657T1 (el) Μεθοδοι και συνθεσεις για κατευθυνομενη απο rna τροποποιηση dna στοχου και για κατευθυνομενη απο rna ρυθμιση της μεταγραφης
CY1122386T1 (el) Χιμαιρικος υποδοχεας αντιγονων και μεθοδοι χρησης εξ αυτου
CY1121223T1 (el) Ποντικοι οι οποιοι εκφραζουν ανθρωποποιημενο μειζον συμπλεγμα ιστοσυμβατοτητας
MX2022001201A (es) Ratones con genes insertados de sirp¿-il15 humanizadas y métodos para usarlos.
CY1121410T1 (el) Μη-ανθρωπινα ζωα που εχουν ενα εξανθρωποποιημενο γονιδιο ρυθμιστικης πρωτεϊνης σηματος
IL264271A (en) Methods of generating natural killer cells
CY1119893T1 (el) Προϊοντα συζευξης cc-1065 αναλογων και διλειτουργικων συνδετων
ECSP14005975A (es) Anticuerpos anti-PHF-tau y sus usos
BR112017010793A2 (pt) animal não humano geneticamente modificado, camundongo, métodos para produzir um animal não humano geneticamente modificado e de triagem de candidatos a fármaco direcionados a um antígeno de interesse, e, modelo de camundongo.
UY34014A (es) Genes sintéticos para expresar proteínas en células de maíz, construcciones, plantas transgénicas, métodos para controlar pestes y composiciones
BR112016011003A2 (pt) animal roedor geneticamente modificado, célula tronco embrionária de camundongo, embrião de camundongo, e, métodos para fabricar um animal roedor e para enxertar células humanas em um camundongo
HK1220990A1 (zh) 缺乏lincrna的非人類動物
MX2017009272A (es) Anticuerpos que penetran en células.
NZ708061A (en) Methods for generating genetically superior animals
CY1119959T1 (el) ΔΕΝΔΡΙΤΙΚΑ ΚΥΤΤΑΡΑ ΥΠΟΒΛΗΘΕΝΤΑ ΣΕ ΧΕΙΡΙΣΜΟ ΣΤΗΝ ΠΟΡΕΙΑ ΣΗΜΑΤΟΔΟΤΗΣΗΣ NFkB
CY1121367T1 (el) Μεθοδοι και συνθεσεις για στοχευμενη τροποποιηση γονιδιωματος
TH170649A (th) หนูตัวรับทีเซลล์แบบปรับแต่งทางพันธุกรรม